Media: Discover Innovative Healing Insights
Collaborations and Breakthroughs Reshaping the Field
SFBW Magazine Feb/March - How Danielle and Clay Fette Sparked a Revolutionary Journey to Healing
To hear Danielle and Clay Fette explain their love story feels like a plot ripped from a science-fiction movie. Danielle, an experienced wound-care nurse in the medical device industry, and Clay, an engineer and pioneer in regenerative medicine, first met in 2009 while assisting a Fort Lauderdale plastic surgeon who was treating a patient with a rare, flesh-eating disease.
MTP featured on ABC news
FORT LAUDERDALE, Fla. (Ivanhoe Newswire) – More than 5.7 million Americans suffer from chronic wounds that won’t heal. Now, a new, easy to use treatment some are calling a “magic powder” is helping patients heal much faster.
EXTRACELLULAR MATRIX BIOLOGY AND FUNCTION
The extracellular matrix (ECM) is a fundamental component of all biological tissues. It consists of an intricate network of proteins and carbohydrate-containing macromolecules that are organized in a tissue-specific manner. Specific ECM phenotypes configure different tissues to meet the requirements for optimal tissue function, so the ratio of each of the ECM components to one another varies across tissue types.
Exosomes Found in the Multi-Tissue Platform (MTP)
Extracellular vesicles (EVs) are small membrane-enclosed structures released by almost every cell in the body. Exosomes are one kind of EV, with diameters ranging from 30-150 nm.1 They are found in all body fluids including urine, blood, breast milk, saliva, cerebrospinal fluid, amniotic fluid, and semen,2 and are cleared from the circulation via sequestration in the liver, spleen, lung, and gastrointestinal tract.
Biocompatibility Testing Summary for the Multi-Tissue Platform
Biocompatibility testing is performed to ensure the safety and regulatory compliance of medical devices, ultimately safeguarding patients and improving healthcare outcomes. The United States Food and Drug Administration (FDA) and the International Organization for Standardization (ISO) require medical product manufacturers to perform several different biocompatibility tests to ensure their products are safe for patients with respect to a wide range of possible adverse reactions.
FetTech, LLC to bring biomaterials expertise to the NSF-PTRME Ecosystem as new Test Bed partner
Read more about how FetTech is collaborating with the Wake Forest Institute for Regenerative Medicine by bringing expertise to the NSF-Piedmont Triad RegenMed Engine (PTRME) ecosystem. This collaboration aims to enhance the development and clinical translation of innovative therapies using FetTech’s Multi-Tissue Platform (MTP) technology.
Chemical Engineering Students’ Research Helps Bring Promising Shingles Breakthrough
Read about how the Rose-Hulman Institute of Technology worked together with FetTech to bring about an innovative project for the biotech startup. This inspired Sanya Dronawat (left) & Lauren Coffey to have additional industry internship and college research experiences with, eventually, future career opportunities.
Collaborative Engineering Drives Groundbreaking Medical Projects | Rose-Hulman Ventures
Discover the way Rose-Hulman Ventures and FetTech are collaborating to bring forward the future of healing & how the multi-tissue platform technology brings wide-ranging promise beyond wound healing.
Tissue Washing Machine StemSys | Rose-Hulman Ventures
Healing wounds from burns and trauma can be a complicated and lengthy process. Medical materials based on actual tissue can make a remarkable difference, and that’s the aim of StemSys, founded by Clay and Danielle Fette.
